QaB2i
2 days ago
Nukkleus ( ) just unveiled an announcement.
In a significant corporate reshuffle, a company issued a note that will mature in September 2024, along with common stock shares convertible under certain exempt securities regulations, to an accredited investor.
Following a settlement agreement, Jamal Khurshid stepped down as CEO and a director, effective September 4, 2024. The board expanded, and Menachem Shalom, who has extensive leadership experience in various tech firms, was appointed as the new CEO. David Rokach, a seasoned investment manager and CEO of Tokara Management, also joined the board. Both appointments are part of the company’s strategic reorganization to strengthen leadership and drive growth
QaB2i
1 month ago
Darren Mercer, CEO of MICT, stated, “Having engaged some of the world’s leading and most highly reputed accounting firms, law firms and M&A investment banks, the quality of the due diligence and financial analysis we have undertaken on Tingo gives us great comfort. We are also significantly assured by the extensive scope of such due diligence and the related reports, and by the fact that no ‘red flags’ or material concerns have been raised.
Stock_Barber
1 month ago
On August 1, 2024 (the “Effective Date”), Nukkleus Inc. (the “Company”) issued a Senior Unsecured Promissory Note (the “Note”) in the principal amount of $515,500 to East Asia Technology Investments Limited (the “Lender”) in consideration of cash proceeds in the amount of $412,075. The Note bears interest of 12.0% per annum and is due and payable six months after issuance. As an additional inducement to provide the loan as outlined under the Note, the Company issued the Lender a Stock Purchase Warrant (“Warrant”) to acquire 1,400,000 shares of common stock at a per share price of $0.25 for a term of five years that may be exercised on a cash or cashless basis. The Lender shall have the right to convert the principal and interest payable under the Note into shares of common stock of the Company at a per share conversion price of $0.25.
QaB2i
3 months ago
Fish. This circus, although it was drinking Tingo the whole time, actually cashed in $0. The fraudulent DNA beat them IMO. The stupidly beat them. The 18 months late to the market beat them. The under funding beat them. The outrageous, irrational, grandiose, dysfunctional, greedy, desperate and corrupt nature of loose SPAC/ Despac regulations vs a traditional IPO beat them. The going stale last chance SPAC beat them.
It’s not every day one gets to totally F U a public company and all of its loyal, trusting shareholders end up taking losses up the whazoo. That’s a particularly nasty type of sociopath that does that. Probably one that likes to race cars.
EOM.